## Abstract Spleen cells, thoracic duct lymphocytes and adherent peritoneal exudate cells from mice immunized to syngeneic plasma cell tumors were capable of transferring specific protective immunity to these tumors. Pre‐treatment of these cells with anti‐Θ serum or anti‐lymphocyte serum, but not w
Tumor immunity to murine plasma-cell tumors. VIII. Immunosuppression of the generation of cytotoxic T cells by murine plasma-cell tumor lines
✍ Scribed by Janis V. Giorgi; Noel L. Warner
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- French
- Weight
- 686 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Previous studies have clearly established that murine plasmacytomas suppress B‐cell responses, but no effects on T‐cell responses have been noted by most investigators. However, in our investigation of the tumor‐associated antigens of plasmacytomas, we have found that immunosuppression plays an important role in the complex interaction between host immune T cells and tumor cells. In these investigations, varying the number of plas‐macytoma cells added to in vitro induction systems separated two different effects which these cells had on the generation of cytotoxic T cells. On the one hand, when appropriate numbers were present, tumor cells acted as immunogens and stimulated the generation of specific killer cells against tumor‐associated antigen or alloantigen which they expressed. In contrast, greater numbers of tumor cells exerted a profound inhibitory effect on the generation of cytotoxic activity when cells inactivated with irradiation were used. Mitomycin‐C inactivation of plasmacytoma cells abrogated this inhibitory activity. In further experiments, MPC‐11 cells that had been inactivated with Mitomycin C were able to prime T cells in vivo, whereas priming by live tumor cells could not be detected in the same situation. It is suggested that immunosuppression by the live tumor cells may account for their inability to prime T cells in vivo. These results indicate that immunosuppression by plasmacytomas may be one of the important variables which influence the generation of cytotoxic T cells against tumor‐associated antigens both in vivo and in vitro.
📜 SIMILAR VOLUMES
## Abstract A plasma‐cell tumor, Cl.18 of C3H/He derivation, exhibits a unique tumor‐associated antigen (TAA) which is detectable both __in vitro__ and also as a tumor‐associated transplantation antigen (TATA) __in vivo.__ Immunoglobulin idiotypic determinants have been thought to be prominent TATA
## Abstract A reproducible __in vitro__ assay for the effect of suppressor T cells on the generation of an __in vitro__ cytotoxic response to a metastatic murine tumor is described. Suppression in this system is maximal. The model uses splenic T cells from DBA/2 mice bearing the MDAY‐D2 metastatic
## Abstract The secretion of antibody by hybridoma cells allows the growth of individual cells to be measured by a hemolytic plaque assay. Similarly, plaque reduction assays are sensitive indicators of tumor immunity. A series of strains of hybridoma have been isolated from an original isolate whic
## Abstract Interleukin (IL‐) 27 is a member of IL‐12 cytokine family with Th1‐promoting and anti‐inflammatory effects. IL‐27 has been shown to facilitate tumor‐specific cytotoxic T lymphocyte (CTL) induction against various tumors. However, IL‐27 suppresses cytokine production of lymphocytes and a
To see whether different antigens expressed by the same tumor are recognized by distinct T-cell receptors (TCR), we used cytotoxic T-lymphocyte (CTL) lines known to lyse in vitro the syngeneic BALB/c adenocarcinoma C-26. Four of these CD3+ CD8+ lines showed 4 different patterns of lysis on a panel o